Business
Cytophage Announces Mailing of Annual and Special Meeting Materials with Board Nominees
(TheNewswire) Veteran Healthcare Executive Thomas Wellner is New Addition to Bo...
About this update from Cytophage Technologies Ltd.
[{"type":"text","content":"Cytophage Announces Mailing of Annual and Special Meeting Materials with Board Nominees\n\n\n (TheNewswire)\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Veteran Healthcare\n \n\n Executive Thomas Wellner is\n \n\n\n\n New Addition to Board Slate for\n2025\n \n\n\n\n WINNIPEG –\n \n\n TheNewswire -\n \n\n June 3, 2025\n \n\n —\nCytophage Technologies Ltd. (“Cytophage” or the “Company”)\n(TSXV: CYTO, FSE: 70G) today announced the mailing of meeting\nmaterials relating to its annual and special meeting of shareholders\n(“ASM”) to be held on Wednesday, June 25th, 2025 at 3:15 p.m.\nWinnipeg time (4:15 p.m. Toronto time) at 400 Fort Whyte Way, Unit\n200A, Oak Bluff, Manitoba.\n \n\n\n\n The following individuals comprise the board slate for\nthe A\n \n\n S\n \n\n M: Dr. Steven\nTheriault, Robert Gabor, Michael Sorkin, John Snisarenko, Michael D.\nCochrane, and William Ollerhead, who are standing for re-election,\nand, a new nominee, Thomas (Tom) Wellner.\n \n\n\n\n Cytophage’s Board of Directors selected Tom Wellner\nto stand for election to the Board based on his leadership experience\nin biotechnology and pharmaceutical companies, in-depth governance\nexperience, and extensive global business network.  Tom Wellner is a\nhighly experienced corporate executive with over three decades of\nglobal experience in biotechnology, pharmaceutical, and healthcare\nservices companies. Following a successful 20-year global career with\nEli Lilly, Mr. Wellner led several healthcare organizations, including\nLilly Germany, LifeLabs/CML Healthcare, and Therapure Biopharma. He\nrecently retired as President and Chief Executive Officer of Revera\nInc., a leading global owner, operator and developer in the senior\nliving/healthcare sector.\n \n\n\n\n Mr. Wellner currently serves on the board of Andlauer\nHealth Group where he chairs the audit committee. He also currently\nserves on the board of the Ontario Teachers Pension Plan and has\npreviously served on the boards of FreshBooks, Novadaq Technologies,\nCipher Pharmaceuticals, Diamedica, and various Revera Inc. entities,\nand has been an advisor to a variety of private equity, venture\ncapital funds and family offices. He has his ICD.D Directors\ndesignation from the Rotman School of Business, and has been a gues...